Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune response to SARS-CoV-2 variants of concern in vaccinated individuals
Matthias Becker, Alex Dulovic, Daniel Junker, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 150

Showing 1-25 of 150 citing articles:

Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis
Deborah Cromer, Megan Steain, Arnold Reynaldi, et al.
The Lancet Microbe (2021) Vol. 3, Iss. 1, pp. e52-e61
Open Access | Times Cited: 342
Advances and Utility of the Human Plasma Proteome
Eric W. Deutsch, Gilbert S. Omenn, Zhi Sun, et al.
Journal of Proteome Research (2021) Vol. 20, Iss. 12, pp. 5241-5263
Open Access | Times Cited: 150
Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies
Alexander Wilhelm, Marek Widera, Katharina Grikscheit, et al.
EBioMedicine (2022) Vol. 82, pp. 104158-104158
Open Access | Times Cited: 148
Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Induced by Natural Infection or Vaccination: A Systematic Review and Pooled Analysis
Xinhua Chen, Zhiyuan Chen, Andrew S. Azman, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. 4, pp. 734-742
Open Access | Times Cited: 104
Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape
Mary Bushman, Rebecca Kahn, Bradford P. Taylor, et al.
Cell (2021) Vol. 184, Iss. 26, pp. 6229-6242.e18
Open Access | Times Cited: 95
Antibody-Mediated Neutralization of Authentic SARS-CoV-2 B.1.617 Variants Harboring L452R and T478K/E484Q
Alexander Wilhelm, Tuna Toptan, Christiane Pallas, et al.
Viruses (2021) Vol. 13, Iss. 9, pp. 1693-1693
Open Access | Times Cited: 82
Potency of BNT162b2 and mRNA‐1273 vaccine‐induced neutralizing antibodies against severe acute respiratory syndrome‐CoV‐2 variants of concern: A systematic review of in vitro studies
Maryam Noori, Seyed Aria Nejadghaderi, Shahnam Arshi, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 2
Open Access | Times Cited: 73
Highly Specific Memory B Cells Generation after the 2nd Dose of BNT162b2 Vaccine Compensate for the Decline of Serum Antibodies and Absence of Mucosal IgA
Eva Piano Mortari, Cristina Russo, M. Vinci, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2541-2541
Open Access | Times Cited: 72
Robust and durable serological response following pediatric SARS-CoV-2 infection
Hanna Renk, Alex Dulovic, Alina Seidel, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 70
Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and naïve healthcare workers
Gemma Moncunill, Ruth Aguilar, Marta Ribes, et al.
EBioMedicine (2022) Vol. 75, pp. 103805-103805
Open Access | Times Cited: 67
Limited Neutralization of Authentic Severe Acute Respiratory Syndrome Coronavirus 2 Variants Carrying E484K In Vitro
Marek Widera, Alexander Wilhelm, Sebastian Hoehl, et al.
The Journal of Infectious Diseases (2021) Vol. 224, Iss. 7, pp. 1109-1114
Open Access | Times Cited: 65
Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis
Monika Strengert, Matthias Becker, Gema Morillas Ramos, et al.
EBioMedicine (2021) Vol. 70, pp. 103524-103524
Open Access | Times Cited: 65
The ins and outs of SARS-CoV-2 variants of concern (VOCs)
Mostafa Salehi‐Vaziri, Mehdi Fazlalipour, Seyed Mahmood Seyed Khorrami, et al.
Archives of Virology (2022) Vol. 167, Iss. 2, pp. 327-344
Open Access | Times Cited: 50
Role of the humoral immune response during COVID-19: guilty or not guilty?
Melyssa Yaugel-Novoa, Thomas Bourlet, Stéphane Paul
Mucosal Immunology (2022) Vol. 15, Iss. 6, pp. 1170-1180
Open Access | Times Cited: 43
Regional and temporal coordinated mutation patterns in SARS-CoV-2 spike protein revealed by a clustering and network analysis
Surendra S. Negi, Catherine H. Schein, Werner Braun
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 40
Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individuals
Katie Healy, Elisa Pin, Puran Chen, et al.
Med (2022) Vol. 3, Iss. 2, pp. 137-153.e3
Open Access | Times Cited: 33
Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
Trung Tran, Eline Benno Vaage, Adi Mehta, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 31
SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies
Daniele Focosi, Marco Tuccori, Andreina Baj, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1211-1211
Open Access | Times Cited: 40
SARS-CoV-2: Emergence of New Variants and Effectiveness of Vaccines
Desh Deepak Singh, Amna Parveen, Dharmendra Kumar Yadav
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 40
Zwitterionic Polymer Electroplating Facilitates the Preparation of Electrode Surfaces for Biosensing
Tuğba Kiliç, Isabel Gessner, Young Kwan Cho, et al.
Advanced Materials (2021) Vol. 34, Iss. 8
Open Access | Times Cited: 39
Genomic sequencing of SARS-CoV-2 in Rwanda reveals the importance of incoming travelers on lineage diversity
Yvan Butera, Enatha Mukantwari, Maria Artesi, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 33
Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta
Maria Fröba, Maximilian Große, Christian Setz, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13202-13202
Open Access | Times Cited: 33
Characteristics of COVID-19 Breakthrough Infections among Vaccinated Individuals and Associated Risk Factors: A Systematic Review
Shilpa Gopinath, Angela Ishak, Naveen Dhawan, et al.
Tropical Medicine and Infectious Disease (2022) Vol. 7, Iss. 5, pp. 81-81
Open Access | Times Cited: 27
Stabilized recombinant SARS-CoV-2 spike antigen enhances vaccine immunogenicity and protective capacity
Christian Meyer zu Natrup, Alina Tscherne, Christine Dahlke, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 24
Open Access | Times Cited: 27
Characterization of Serum and Mucosal SARS-CoV-2-Antibodies in HIV-1-Infected Subjects after BNT162b2 mRNA Vaccination or SARS-CoV-2 Infection
Katja Schmidt, Ellen G. Harrer, Koray Taşçılar, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 651-651
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top